Stem cell research offers hope for Visio-patients (Reuters)
WASHINGTON (Reuters)-Portland, Oregon, Christopher Goodrich can be expected to stick a needle in her eye.
Goodrich hopes one clinical research, which received only in the food and drug administration, only the second research accepted throughout the world to test the human embryonic stem cells in humans, the go-ahead of the first patients enrolled in.
Advanced cell technology, a small Massachusetts-based biotechnology company, which has struggled to raise the human embryonic stem cell Lab clinic begins recruitment and Massachusetts patients 12 Oregon rare eye condition, i.e. Stargardt's macular dystrophy.
Goodrich, 55, retired last year in his job as a coordinator of Portland State University services veteran's macular dystrophy when his Stargardt viewing experience, and suddenly deteriorated.
Like most patients Goodrich had seen his Vision to get steadily worse his young adults for years.
"Glasses help very, very little," Goodrich said in an interview with the phone.
Macular degeneration "what is that that centralizes your own eye, that in the case of the part of all? The cells die. You know how a shotgun blast displays? It is what I see. Is from all over the place. I can see something in my eye located at the bottom of the screen and take something wrong at and then it is not visible. "
Goodrich Is infuriating and do anything to get better, even allow poke in the eye of a needle into his doctor in his eye and infuse human human embryonic stem cells that ACT hopes to take up residence and replace missing cells.
"I've made a list of the let me can do everything and I would like to see everything," Goodrich says.
OTHER EYE DISEASE IN SIGHTS
This is the most immediate promise of human embryonic stem cell research--these immature cells can be coaxed partially down the main road coming to body tissue and fluid displacement into the type and you want to get the process of other cells grow and renewal.
Advanced cell Technology, the product has been trained in human Retinal cell become human embryonic stem cells.
This first clinical trial for only a few thousand of these cells have one eye of each of the gas, mostly as a volunteer, please check that it is safe to do so.
Act, according to Dr. Robert Lanza, taking part in the experiment doctors can watch it right in real-time, as it is possible to examine the eye and see the retina has taken up normal residence in the opening of the cells.
And can be continually checks to see if it is to improve the patients ' vision is.
Stargardt's affects only 30 000-50 000 Americans American Macular Degeneration Foundation to be named after him, but the ACT has a much wider market If this survey succeeds-specifies the age-related macular degeneration in attractions.
The problem affects any blinding operation for more than 30 million people around the world, and people over 60 in the United States, the leading cause of that awful.
Goodrich has been a patient of Dr. Peter Francis, Oregon Health & Science University, which is one of the researchers in the trial version of the ACT. But Lanza said, all patients must be carried out in the approval process.
(Editing Cynthia Osterman)
Comments
Post a Comment